John Groetelaars is the President & CEO at Hillrom.

John P. Groetelaars joined Hillrom as president and chief executive officer in May 2018. Previously, Mr. Groetelaars was executive vice president and president of Becton, Dickinson and Company’s (BD) Interventional Segment, where his responsibilities included global strategic, operational, commercial and financial performance, and delivering the segment’s innovation platform. Prior to the BD acquisition of C.R. Bard, Mr. Groetelaars was group president at Bard, which he had joined in 2008. He previously held positions of increasing responsibility with Boston Scientific Corporation, Guidant Corporation and Eli Lilly. Mr. Groetelaars earned his bachelor’s in Mechanical Engineering from Kettering University in Michigan, and an MBA from Columbia University in New York. He is a current board member of AdvaMed.